Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
Key Petroleum Ltd
ASX:KEY
|
AU |
|
Foghorn Therapeutics Inc
NASDAQ:FHTX
|
US |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
|
First Financial Bankshares Inc
NASDAQ:FFIN
|
US |
|
Advenica AB (publ)
F:65R
|
SE |
|
C
|
China Coal Energy Co Ltd
XMUN:CVV
|
CN |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
|
Orange SA
PAR:ORA
|
FR |
|
F
|
Federated Hermes Inc
DUS:3KC
|
US |
Shareholder Yield
Current shareholder yield for RXRX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RXRX Price
Recursion Pharmaceuticals Inc
| Average Annual Return | -20.61% |
| Standard Deviation of Annual Returns | 32.6% |
| Max Drawdown | -86% |
| Market Capitalization | 2.1B USD |
| Shares Outstanding | 594 730 000 |
| Percentage of Shares Shorted | 31.67% |
